Hormonal effects of different doses of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.

Author: CekanS Z, DiczfalusyE, FritjofssonA, HögbergB, NorlénB J, RajalakshmiM

Paper Details 
Original Abstract of the Article :
Ten patients with previously untreated prostatic carcinoma were studied to evaluate the hormonal effects of different doses of estramustine phosphate (Estracyt). The drug was given by mouth in increasing doses; during the first month 70 mg daily, during the second 140 mg, during the third 280 mg and...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.3109/00365598109181211

データ提供:米国国立医学図書館(NLM)

Hormonal Effects of Estramustine Phosphate in Prostatic Carcinoma

Estramustine phosphate (Estracyt), a hormonal therapy for prostatic carcinoma, has been shown to have a potent anti-tumor effect. This research investigates the hormonal effects of different doses of Estracyt in patients with previously untreated prostatic carcinoma. The study involved 10 patients who received increasing doses of Estracyt over a four-month period.

Hormonal Effects of Estramustine Phosphate

The results demonstrate that even the lowest dose of Estracyt significantly reduced testosterone levels and other hormone levels, indicating a potent hormonal effect. The study found that the maximum hormonal effect was achieved at the lowest dose, with no further reduction observed with higher doses. The clinical effect of the treatment was initially excellent, but complications and refractoriness led to discontinuation in some patients.

Understanding Estramustine Phosphate's Mechanism

This research provides valuable insights into the hormonal effects of Estracyt, highlighting its potent hormonal activity and potential benefits for managing prostatic carcinoma. It's like finding a hidden spring in the desert of prostate cancer research, revealing a promising avenue for developing more targeted and effective therapies.

Dr.Camel's Conclusion

This research sheds light on the hormonal effects of Estracyt, a valuable tool in the fight against prostate cancer. Understanding the mechanism of action of this drug is crucial for developing more effective and personalized therapies. It's like finding a hidden oasis in the desert, offering a potential solution to a challenging condition.

Date :
  1. Date Completed 1981-08-10
  2. Date Revised 2019-09-04
Further Info :

Pubmed ID

6787701

DOI: Digital Object Identifier

10.3109/00365598109181211

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.